
John Eric Hug
Examiner (ID: 208, Phone: (571)272-1192 , Office: P/1741 )
| Most Active Art Unit | 1731 |
| Art Unit(s) | 1741, 1791, 1731, 1748 |
| Total Applications | 1588 |
| Issued Applications | 1319 |
| Pending Applications | 41 |
| Abandoned Applications | 236 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10220343
[patent_doc_number] => 20150105335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'NOVEL PEPTIDE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/506497
[patent_app_country] => US
[patent_app_date] => 2014-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20159
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14506497
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/506497 | Peptide compositions | Oct 2, 2014 | Issued |
Array
(
[id] => 10573130
[patent_doc_number] => 09295752
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-03-29
[patent_title] => 'Bioadhesive for occluding vessels'
[patent_app_type] => utility
[patent_app_number] => 14/502413
[patent_app_country] => US
[patent_app_date] => 2014-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10045
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14502413
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/502413 | Bioadhesive for occluding vessels | Sep 29, 2014 | Issued |
Array
(
[id] => 10298831
[patent_doc_number] => 20150183830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'METHODS FOR PREPARING PURIFIED LIPOPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/500469
[patent_app_country] => US
[patent_app_date] => 2014-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16398
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14500469
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/500469 | METHODS FOR PREPARING PURIFIED LIPOPEPTIDES | Sep 28, 2014 | Abandoned |
Array
(
[id] => 12286162
[patent_doc_number] => 09932376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-03
[patent_title] => Analogues of temporin-SHa and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/021948
[patent_app_country] => US
[patent_app_date] => 2014-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 11613
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021948
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/021948 | Analogues of temporin-SHa and uses thereof | Sep 25, 2014 | Issued |
Array
(
[id] => 9910214
[patent_doc_number] => 20150065416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'NOVEL DRUG COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 14/472866
[patent_app_country] => US
[patent_app_date] => 2014-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 15506
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14472866
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/472866 | NOVEL DRUG COMBINATION | Aug 28, 2014 | Abandoned |
Array
(
[id] => 11907081
[patent_doc_number] => 09775878
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Methods for treating bacterial infections using oritavancin and polymyxins'
[patent_app_type] => utility
[patent_app_number] => 14/914773
[patent_app_country] => US
[patent_app_date] => 2014-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7646
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914773
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/914773 | Methods for treating bacterial infections using oritavancin and polymyxins | Aug 27, 2014 | Issued |
Array
(
[id] => 11009735
[patent_doc_number] => 20160206688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'METHODS FOR TREATING BACTEREMIA AND OSTEOMYELITIS USING ORITAVANCIN'
[patent_app_type] => utility
[patent_app_number] => 14/914792
[patent_app_country] => US
[patent_app_date] => 2014-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10838
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914792
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/914792 | METHODS FOR TREATING BACTEREMIA AND OSTEOMYELITIS USING ORITAVANCIN | Aug 25, 2014 | Abandoned |
Array
(
[id] => 12445602
[patent_doc_number] => 09981047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Peptidic nanodelivery composition targeting two receptors
[patent_app_type] => utility
[patent_app_number] => 14/912997
[patent_app_country] => US
[patent_app_date] => 2014-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 99
[patent_no_of_words] => 13491
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14912997
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/912997 | Peptidic nanodelivery composition targeting two receptors | Aug 18, 2014 | Issued |
Array
(
[id] => 11225345
[patent_doc_number] => 09453060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Protein engineered systems for delivery of molecules'
[patent_app_type] => utility
[patent_app_number] => 14/910794
[patent_app_country] => US
[patent_app_date] => 2014-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 21
[patent_no_of_words] => 9802
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14910794
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/910794 | Protein engineered systems for delivery of molecules | Aug 10, 2014 | Issued |
Array
(
[id] => 13287013
[patent_doc_number] => 10154678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Method for producing hydrolysed keratinaceous material
[patent_app_type] => utility
[patent_app_number] => 14/908577
[patent_app_country] => US
[patent_app_date] => 2014-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5541
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908577
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/908577 | Method for producing hydrolysed keratinaceous material | Jul 28, 2014 | Issued |
Array
(
[id] => 11011021
[patent_doc_number] => 20160207975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'CGRP AGONIST PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/908515
[patent_app_country] => US
[patent_app_date] => 2014-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7146
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908515
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/908515 | CGRP agonist peptides | Jul 28, 2014 | Issued |
Array
(
[id] => 10966928
[patent_doc_number] => 20140369960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'CONJUGATED BIOLOGICAL MOLECULES AND THEIR PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 14/444859
[patent_app_country] => US
[patent_app_date] => 2014-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11489
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14444859
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/444859 | Conjugated biological molecules and their preparation | Jul 27, 2014 | Issued |
Array
(
[id] => 10987441
[patent_doc_number] => 20160184386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'AQUEOUS SUSTAINED RELEASE COMPOSITIONS OF LHRH ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 14/908953
[patent_app_country] => US
[patent_app_date] => 2014-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8069
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908953
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/908953 | AQUEOUS SUSTAINED RELEASE COMPOSITIONS OF LHRH ANALOGUES | Jul 20, 2014 | Abandoned |
Array
(
[id] => 11282673
[patent_doc_number] => 09498511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Methods related to the treatment of neurodegenerative and inflammatory conditions'
[patent_app_type] => utility
[patent_app_number] => 14/323557
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 109
[patent_no_of_words] => 26999
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323557
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/323557 | Methods related to the treatment of neurodegenerative and inflammatory conditions | Jul 2, 2014 | Issued |
Array
(
[id] => 10593462
[patent_doc_number] => 09314533
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-19
[patent_title] => 'Conformations of divergent peptides with mineral binding affinity'
[patent_app_type] => utility
[patent_app_number] => 14/317179
[patent_app_country] => US
[patent_app_date] => 2014-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 9820
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14317179
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/317179 | Conformations of divergent peptides with mineral binding affinity | Jun 26, 2014 | Issued |
Array
(
[id] => 13142321
[patent_doc_number] => 10088487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Method for the quantitative characterization of amyloid and/or aggregating peptides and/or proteins in a sample
[patent_app_type] => utility
[patent_app_number] => 14/902754
[patent_app_country] => US
[patent_app_date] => 2014-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 6496
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14902754
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/902754 | Method for the quantitative characterization of amyloid and/or aggregating peptides and/or proteins in a sample | Jun 24, 2014 | Issued |
Array
(
[id] => 12959200
[patent_doc_number] => 09872515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Low-concentration nutritional composition
[patent_app_type] => utility
[patent_app_number] => 14/312708
[patent_app_country] => US
[patent_app_date] => 2014-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2707
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14312708
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/312708 | Low-concentration nutritional composition | Jun 23, 2014 | Issued |
Array
(
[id] => 12959200
[patent_doc_number] => 09872515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Low-concentration nutritional composition
[patent_app_type] => utility
[patent_app_number] => 14/312708
[patent_app_country] => US
[patent_app_date] => 2014-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2707
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14312708
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/312708 | Low-concentration nutritional composition | Jun 23, 2014 | Issued |
Array
(
[id] => 12959200
[patent_doc_number] => 09872515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Low-concentration nutritional composition
[patent_app_type] => utility
[patent_app_number] => 14/312708
[patent_app_country] => US
[patent_app_date] => 2014-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2707
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14312708
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/312708 | Low-concentration nutritional composition | Jun 23, 2014 | Issued |
Array
(
[id] => 12959200
[patent_doc_number] => 09872515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Low-concentration nutritional composition
[patent_app_type] => utility
[patent_app_number] => 14/312708
[patent_app_country] => US
[patent_app_date] => 2014-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2707
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14312708
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/312708 | Low-concentration nutritional composition | Jun 23, 2014 | Issued |